Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

May 19, 2016, 09:00 ET Role of Diet Over-Prioritized in Gout Treatment

 A new survey¡ from the Gout & Uric Acid Education Society (GUAES) finds many Americans with gout may be placing too much emphasis on...


May 19, 2016, 09:00 ET The Michael J. Fox Foundation for Parkinson's Research Joins Multinational Critical Path for Parkinson's Consortium

 The Michael J. Fox Foundation for Parkinson's Research (MJFF), with Parkinson's UK and the Critical Path Institute (C-Path) in Tucson,...


May 19, 2016, 08:59 ET BioLight Expands Its Product Portfolio With Eye Drops for Dry Eye Syndrome

BioLight Life Sciences Ltd. (TASE: BOLT), ("BioLight" or the "Company"), an emerging global ophthalmic company focused on the discovery,...


May 19, 2016, 08:54 ET OBI Pharma va présenter de nouvelles données à la réunion annuelle de la Société américaine d'oncologie clinique (ASCO)

La présentation orale mettra en lumière les résultats d'un essai de phase II/III portant sur l'immunothérapie...


May 19, 2016, 08:30 ET Neurotrope Enters Into Research Collaboration With the International Rett Syndrome Foundation / Rettsyndrome.org

 Neurotrope, Inc. (OTCQB: NTRP), a clinical-stage company developing a disruptive therapy for the treatment of severe Alzheimer's disease...


May 19, 2016, 08:00 ET Astellas Oncology Announces Data to be Presented at 2016 ASCO Annual Meeting

Astellas announced today a selection of abstracts it will present on early phase data for ASP8273 in patients with EGFR mutation positive non-small...


May 19, 2016, 08:00 ET MabVax Therapeutics' Antibody Discovery Platform and HuMab-5B1 Cancer Therapeutic Featured in Presentation at America's Antibody Congress

 MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX), a clinical-stage immuno-oncology drug development company, announces that Paul Maffuid, PhD,...


May 19, 2016, 08:00 ET Infinity Announces Presentations On Investigational Development Candidates, Duvelisib And IPI-549, At Upcoming EHA And ASCO Meetings

 Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that new data will be presented for duvelisib, an investigational, oral, dual...


May 19, 2016, 08:00 ET Decipher Prostate Cancer Test Guides Timing of Postoperative Radiotherapy

GenomeDx Biosciences today announced the publication of a multi-institution validation study of the Decipher® Prostate Cancer Classifier, a...


May 19, 2016, 07:05 ET Merrimack Announces a Leading-edge Biomarker-Selected, Multi-Arm Basket Trial that Matches Patients with Most Appropriate Combination Regimens

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) announced today the initiation of a biomarker-selected, multi-arm Phase 1 clinical study in...


May 19, 2016, 07:00 ET Celator Pharmaceuticals® Announces VYXEOS™ Granted Breakthrough Therapy Designation

 Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today announced that the United States Food and Drug Administration (FDA) granted Breakthrough...


May 19, 2016, 07:00 ET VolitionRx to Present Data Demonstrating Accuracy of NuQ® Blood Test in Detecting Colorectal Cancer at World Endoscopy Organization (WEO) Meeting

 VolitionRx Limited (NYSE MKT: VNRX) today announced that its Chief Medical Officer & Head of U.S. Operations, Dr. Jason Terrell, is...


May 19, 2016, 07:00 ET BioLineRx's BL-8040 to be Presented at Upcoming Scientific Conferences

BioLineRx Ltd. (NASDAQ/TASE: BLRX) announced today that BL-8040, its lead platform for the treatment of multiple cancer and hematological...


May 19, 2016, 07:00 ET Regen BioPharma, Inc. Announces ucVax: Universal Donor Cancer Cellular Immunotherapy

Regen BioPharma, Inc. (OTCBB: RGBP), (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today initiation of a preclinical development...


May 19, 2016, 07:00 ET Merrimack and Baxalta Announce Initiation of Phase 1 Study of MM-151 in Combination with the ONIVYDE® (irinotecan liposome injection) Regimen in Metastatic Colorectal Cancer

 Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) and Baxalta Incorporated (NYSE: BXLT) today jointly announced the initiation of a Phase 1...


May 19, 2016, 07:00 ET Lyme Bacteria Hides Inside Parasitic Worms, Causing Chronic Brain Diseases

 The examination of autopsied brain tissues from patients who died of serious neurological conditions has revealed that many tick-borne...


May 19, 2016, 06:30 ET Oncolytics Biotech® Inc. Reports Preliminary Data from Randomized Phase II Study of REOLYSIN® in Colorectal Cancer

--REOLYSIN® Demonstrates Increase in Objective Response Rates in Female Patients  and in Patients with Liver Metastases-- CALGARY, May...


May 19, 2016, 06:00 ET Global Blood Therapeutics Announces Presentation of New GBT440 Data in Sickle Cell Disease at the European Hematology Association's 21st Congress

 Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT), a biopharmaceutical company developing novel therapeutics for the treatment of...


May 19, 2016, 06:00 ET Oncolytics Biotech® Inc. Reports Preliminary Data from Randomized Phase II Study of REOLYSIN® in Non-Small Cell Lung Cancer

--Randomized REOLYSIN® Data Correlates Genetic Status to Patient Outcomes-- CALGARY, May 19, 2016 /PRNewswire/ - Oncolytics Biotech Inc....


May 19, 2016, 05:00 ET OBI Pharma to Present New Data at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting

OBI Pharma, Inc., a Taiwan biotech company (TPex: 4174), today announced that the company-sponsored abstract detailing the full results of its...


Most Viewed